Articles:

Wild-type p53 demonstrates functional dominance in a human colon carcinoma cell line in which it induces reversible growth arrest

B Yang, PJ Stambrook, and SD Markowitz
Clin Cancer Res 1996 2: 1639 [Abstract] [PDF]  

Wild-type p53 protein potentiates cytotoxicity of therapeutic agents in human colon cancer cells

B Yang, JR Eshleman, NA Berger, and SD Markowitz
Clin Cancer Res 1996 2: 1649 [Abstract] [PDF]  

Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model

SA Eicher, GL Clayman, TJ Liu, EJ Shillitoe, KA Storthz, JA Roth, and R Lotan
Clin Cancer Res 1996 2: 1659 [Abstract] [PDF]  

Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation

FR Spitz, D Nguyen, JM Skibber, RE Meyn, RJ Cristiano, and JA Roth
Clin Cancer Res 1996 2: 1665 [Abstract] [PDF]  

13q14 deletions are not primary events in B-cell chronic lymphocytic leukemia: a study of 100 patients using fluorescence in situ hybridization

H Avet-Loiseau, MC Devilder, R Garand, I Bouyge, MJ Rapp, N Milpied, JL Harousseau, JP Moisan, and R Bataille
Clin Cancer Res 1996 2: 1673 [Abstract] [PDF]  

Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer

Y Takahashi, KR Cleary, M Mai, Y Kitadai, CD Bucana, and LM Ellis
Clin Cancer Res 1996 2: 1679 [Abstract] [PDF]  

Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusion

PJ O'Dwyer, PB Laub, D DeMaria, M Qian, D Reilly, B Giantonio, AL Johnston, EY Wu, L Bauman, NJ Clendeninn, and JM Gallo
Clin Cancer Res 1996 2: 1685 [Abstract] [PDF]  

Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study

SK Chambers, CA Davis, PE Schwartz, EI Kohorn, and JT Chambers
Clin Cancer Res 1996 2: 1693 [Abstract] [PDF]  

Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients

SK Chambers, CA Davis, JT Chambers, PE Schwartz, MI Lorber, and RE Hschumacher
Clin Cancer Res 1996 2: 1699 [Abstract] [PDF]  

Decreases in levels of serum fibronectin predict the severity of vascular leak syndrome in patients treated with ricin A chain-containing immunotoxins

R Baluna, EA Sausville, MJ Stone, MA Stetler-Stevenson, JW Uhr, and ES Vitetta
Clin Cancer Res 1996 2: 1705 [Abstract] [PDF]  

Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin 3 fusion protein, on human tumor colony-forming units taken directly from patients

MA Izquierdo, D Degen, E Raymond, D Caron, V Ortiz, P Banks, and DD Von Hoff
Clin Cancer Res 1996 2: 1713 [Abstract] [PDF]  

Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days

I Wolff, K Bench, JH Beijnen, U Bruntsch, F Cavalli, J de Jong, Y Groot, O van Tellingen, J Wanders, and C Sessa
Clin Cancer Res 1996 2: 1717 [Abstract] [PDF]  

Paclitaxel (Taxol(R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cells

D Belotti, M Rieppi, MI Nicoletti, AM Casazza, T Fojo, G Taraboletti, and R Giavazzi
Clin Cancer Res 1996 2: 1725 [Abstract] [PDF]  

Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes

A Sandoval, U Consoli, and W Plunkett
Clin Cancer Res 1996 2: 1731 [Abstract] [PDF]  

Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain

NI Obiri, SR Husain, W Debinski, and RK Puri
Clin Cancer Res 1996 2: 1743 [Abstract] [PDF]  

Effect of omega-3 fatty acids on the progression of metastases after the surgical excision of human breast cancer cell solid tumors growing in nude mice

DP Rose, JM Connolly, and M Coleman
Clin Cancer Res 1996 2: 1751 [Abstract] [PDF]  

Quantitation of somatostatin receptor type 2 gene expression in neuroblastoma cell lines and primary tumors using competitive reverse transcription-polymerase chain reaction

R Sestini, C Orlando, A Peri, C Tricarico, M Pazzagli, M Serio, A Pagani, G Bussolati, S Granchi, and M Maggi
Clin Cancer Res 1996 2: 1757 [Abstract] [PDF]  

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer

GE Trivers, VM De Benedetti, HL Cawley, G Caron, AM Harrington, WP Bennett, JR Jett, TV Colby, H Tazelaar, P Pairolero, RD Miller, and CC Harris
Clin Cancer Res 1996 2: 1767 [Abstract] [PDF]  

Expression of the Mr 67,000 laminin receptor is an adverse prognostic indicator in human thyroid cancer: an immunohistochemical study

F Basolo, L Pollina, F Pacini, G Fontanini, S Menard, V Castronovo, and G Bevilacqua
Clin Cancer Res 1996 2: 1777 [Abstract] [PDF]  

Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma

M Furihata, T Ishikawa, A Inoue, C Yoshikawa, H Sonobe, Y Ohtsuki, K Araki, and S Ogoshi
Clin Cancer Res 1996 2: 1781 [Abstract] [PDF]  

Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium

JM Kurie, HJ Shin, JS Lee, RC Morice, JY Ro, SM Lippman, WN Hittelman, R Yu, JJ Lee, and WK Hong
Clin Cancer Res 1996 2: 1787 [Abstract] [PDF]  

Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers

X Xu, MJ Stower, IN Reid, RC Garner, and PA Burns
Clin Cancer Res 1996 2: 1795 [Abstract] [PDF]  

Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination

A Franchi, O Gallo, V Boddi, and M Santucci
Clin Cancer Res 1996 2: 1801 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.